Characteristics | Univariate analysis | Multivariate analysisb | ||||
---|---|---|---|---|---|---|
 | p-value | OR | CI 95% | p-value | Aj OR | CI 95% |
Total time in use of HAART | 0.000a | - | - | 0.013a | 0.981 | 0.96-0.99 |
Concomitant medications over 30 consecutive days in previous year | 0.002a | Â | Â | 0.109 | Â | Â |
Yes | Â | Â | - | Â | Â | - |
No | Â | 0.29 | 0.13-0.65 | Â | 0.423 | 0.14-1.21 |
Modifications in HAART before previous year due to abandonment or poor adherence | 0.018a | Â | Â | 0.159 | Â | Â |
No | Â | Â | - | Â | Â | - |
Yes | Â | 3.39 | 1.33-8.65 | Â | 2.852 | 0.66-12.25 |
Regimen containing zidovudine | 0.021a | Â | Â | 0.359 | Â | Â |
Yes | Â | Â | - | Â | Â | - |
No | Â | 2.28 | 1.11-4.66 | Â | 1.601 | 0.58-4.37 |
AIDS defining illness prior to HAART | 0.040a | Â | Â | 0.515 | Â | Â |
Yes | Â | 0.88 | 0.28-2.77 | Â | 1.475 | 0.45-4.74 |
No | Â | Â | - | Â | Â | - |
Irregular use of HAART in previous year | 0.071a | Â | Â | 0.403 | Â | Â |
Yes | Â | 2.22 | 0.91-5.39 | Â | 1.888 | 0.42-8.36 |
No | Â | Â | - | Â | Â | - |
Nadir CD4-count | 0.000a | - | - | 0.000a | 0.985 | 0.97-0.99 |
Time of undetectable HIVVL | 0.000a | - | - | 0.037a | 0.969 | 0.94-0.99 |